SQZ BIOTECHNOLOGIES COMPANY Increase (Decrease) in Accrued Liabilities
SQZ BIOTECHNOLOGIES COMPANY reported Increase (Decrease) in Accrued Liabilities of -$4.54 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was -$509.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was -$10.00K, a 100.84% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$4.02M, a 334.38% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $1.07M, a 4.38% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for fiscal 2022 was $2.08M.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for fiscal 2021 was -$283.00K, a 215.04% decline from fiscal 2020.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for fiscal 2020 was $246.00K, a 92.72% decline from fiscal 2019.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accrued liabilities for fiscal 2019 was $3.38M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$519.00K derived: sum of 2 quarters · filed 2023-11-08 | -$4.54M 10-Q · filed 2023-11-08 | -$3.47M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.03M 10-Q · filed 2023-08-10 | -$2.96M derived: sum of 3 quarters · filed 2023-08-10 | -$4.85M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | -$4.02M 10-Q · filed 2023-05-10 | -$2.95M derived: sum of 2 quarters · filed 2023-05-10 | -$4.84M derived: sum of 3 quarters · filed 2023-11-08 | -$3.65M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$818.00K derived: sum of 2 quarters · filed 2023-11-08 | $367.00K derived: sum of 3 quarters · filed 2023-11-08 | $2.08M 10-K · filed 2023-03-22 |
| 2022-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$703.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.01M 10-Q · filed 2023-11-08 | $2.13M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.90M 10-Q · filed 2023-08-10 | $4.02M derived: sum of 3 quarters · filed 2023-08-10 | $4.44M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.72M 10-Q · filed 2023-05-10 | $2.83M derived: sum of 2 quarters · filed 2023-05-10 | $3.25M derived: sum of 3 quarters · filed 2023-05-10 | $4.08M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.53M derived: sum of 2 quarters · filed 2023-03-22 | $2.36M derived: sum of 3 quarters · filed 2023-03-22 | -$283.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.24M derived: sum of 2 quarters · filed 2022-11-09 | -$1.40M 10-Q · filed 2022-11-09 | $113.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $827.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.82M 10-Q · filed 2022-08-04 | -$303.00K derived: sum of 3 quarters · filed 2022-08-04 | $1.12M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$2.65M 10-Q · filed 2022-05-10 | -$1.13M derived: sum of 2 quarters · filed 2022-05-10 | $291.00K derived: sum of 3 quarters · filed 2022-05-10 | $259.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $2.94M derived: sum of 2 quarters · filed 2022-03-16 | $2.90M derived: sum of 3 quarters · filed 2022-03-16 | $246.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.39M derived: sum of 2 quarters · filed 2021-11-10 | -$1.27M 10-Q · filed 2021-11-10 | $732.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.69M 10-Q · filed 2021-08-04 | -$689.00K derived: sum of 3 quarters · filed 2021-08-04 | |
| 2020-03-31 | -$2.66M 10-Q · filed 2021-05-11 | -$657.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $3.38M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $1.38M 10-Q · filed 2020-12-10 |